Answers are grounded in this paper and cite their sources.
Neurological deterioration in the hours following the onset of stroke is not rare. Depending on the diagnostic criteria and the time from onset of symptoms to the first evaluation, neurological deterioration has been reported in 26–43% of cerebral infarcts (CI) [1, 2, 3, 4, 5, 6, 7, 8], and 33–51% of intracerebral hemorrhages (ICH) [9, 10]. In both types of stroke, neurological deterioration is associated with increased mortality and morbidity [3, 5, 6, 8, 11].Early detection and prediction of neurological deterioration, identification of the responsible mechanisms and their correction, are the basis of an effective therapy.The different terms used (stroke in evolution, evolving stroke, progressing stroke, deteriorating stroke) to identify those patients with stroke and clinical worsening have led to some confusion. At present there is a tendency to identify deteriorating stroke with any neurological worsening, whereas the term progressing stroke is used in those instances in which neurological worsening obeys to the progression of the ischemia, ICH, or to the increase of tissular necrosis [12].The timing of worsening is likely related to its mechanism. The clinical worsening that appears within the first 48/72 h is more likely related to an increase of ischemia or ICH (progressing stroke), while the underlying cause of delayed worsening (3–7 days) is more frequently due to systemic causes (deteriorating stroke) [8, 13].It is often clinically easy to observe the neurological worsening of a patient with stroke. Although the need to standardize diagnostic criteria forces us to use objective procedures (neurological scales), these measurements are on many occasions less sensitive than the assessment of an experienced clinician. According to published criteria, deteriorating stroke (or progressing stroke) is defined when there is a fall in 1 point on the Canadian Stroke Scale, 2 or more points on the Scandinavian Stroke Scale, or 2 or more points on the National Institute of Health Stroke Scale [2, 3, 4, 5, 6, 8](table 1).In some patients it is difficult to differentiate between deteriorating stroke and recurrent stroke. It is accepted that in deteriorating stroke neurological worsening takes place slowly with an intensification of previous deficit or appearance of new symptoms corresponding to the same vascular territory. On the other hand, recurrent stroke often appears suddenly, after a week or more from the initial episode and in a different vascular territory [12].In recent years, risk factors of neurological deterioration in CI have been described, including clinical, neuroimaging, ultrasonographic and biochemical parameters (table 2); some are associated with the risk of early neurological deterioration (progressive infarct), while others are more related to the development of delayed worsening.Old age and severe neurological deficits on admission are predictive factors of delayed neurological deterioration, possibly due to systemic complications [3, 8]. A history of diabetes mellitus and coronary disease are predictors of early neurological deterioration; both factors are markers for intracerebral and extracerebral atherosclerotic disease and poor collateral circulation. Abnormal blood pressure is also a predictor of early neurological deterioration. Hypotension, whether iatrogenic or secondary to cardiac disease, may lead to an increase of the cerebral lesion as the result of perfusion failure [16, 17]. Contrarily, arterial hypertension at stroke onset constitutes part of the acute phase reaction, such as hyperthermia or hyperglycemia, and its magnitude parallels the intensity of the neurological deficit [2, 3, 8].Hyperthermia in the first 24 h from the onset of stroke, even if mild, is an important predictor of poor prognosis and early neurological deterioration independently of its etiology [18, 19, 20]. For every 1°C increase in body temperature, the relative risk of early neurological deterioration rises 9.2 times [6]. Hyperthermia developed after the first 24 h loses its predictive value, especially in patients with hyperthermia of infectious origin [15]. Generalized headache at the start of CI is another predictive marker of early worsening [14]. Headache in these patients may be the expression of the repeated waves of spreading depression that can set off the fluctuations of neurological deficit during the first hours of stroke [21].Early cortical or cortico-subcortical hypodensity on CT scan [4], or the visualization of hyperdensity of the middle cerebral artery [8], are important predictors of early deterioration. Stroke progression is more frequent in cortical than in deep infarcts (42.6 vs. 18.9%, p < 0.0001) [22]and, possibly, in vertebrobasilar infarcts than in those of the carotid territory. However, there is no convincing evidence that the hemorrhagic transformation of a bland infarct is associated with early or late neurological worsening [12]. Rather, hemorrhagic transformation is a marker of large infarcts [8, 23, 24]. The presence of mass effect on the baseline CT is a marker of early and late neurological deterioration [8].The angiographic demonstration of a large extracranial or intracranial artery occlusion is another predictive factor of early neurological deterioration [4]. In 91% of patients with deteriorating infarct, there is an arterial occlusion, compared to 71% of patients with nondeteriorating infarct, more frequently localized in the internal carotid or in the middle cerebral artery [25]. The occlusion of an arterial trunk, with little or no collateral circulation, gives rise to a rapid development of early hypodensity in the CT, which is another important predictor of deteriorating infarct [26]. There are no studies evaluating the role of angio-CT or angio-MRI in the identification of stroke patients susceptible to neurological deterioration.Acute diffusion and perfusion MRI, positron emission tomography (PET), single photon emission CT (SPECT) and xenon CT are new imaging techniques that facilitate identification of the ischemic cerebral tissue earlier than CT scan; however, there are as yet no studies assessing their predictive value in deteriorating infarct [27, 28, 29, 30].Transcranial Doppler has recently been added as a useful and reliable technique in the identification of patients at risk of deteriorating infarct. The absence of flow in the middle cerebral artery during the first 6 h from the start of symptomatology appears in 40% of patients who deteriorate, in 22% of stable patients, and in 7% of those who improve [31].High plasmatic concentrations of glucose or fibrinogen on admission are associated with a higher risk of early stroke deterioration [2, 4, 6, 18, 32]. Hyperglycemia, both in diabetic and nondiabetic patients, represents a manifestation of the acute phase response with no prognostic value after the first 24 h from the onset of symptoms [32]. The acute phase reaction peaks between 8 and 12 h from the start of symptoms. Time differences to measurement of acute phase reactants could explain in part the disparities observed in studies evaluating predictors of clinical worsening [33].At present, glutamate is the most powerful biochemical predictor of deteriorating CI [12]. Plasma levels of glutamate >200 µmol/l and CSF levels >8.2 mol/l during the first 24 h of symptoms predict early neurological deterioration with a probability of 92% [5]. A concentration of serum ferritin >285 ng/ml also predicts early neurological deterioration in CI [12].Stroke progression includes the conversion of the ischemic penumbra into irreversible damage [34]. Repetitive depolarization waves in the area surrounding the core of the lesion, and an increased metabolic rate in areas of reduced blood flow could be responsible [35]. However, as the penumbra is clinically expressive from the onset of symptoms it is likely that worsening also implies the recruitment of normal cerebral tissue that surrounds the ischemic lesion.The excitotoxic hypothesis of ischemic cerebral injury postulates that the decline in cerebral perfusion below critical values gives rise to the accumulation of glutamate and glycine within and around the ischemic zone. These neuroexcitatory amino acids would stimulate specific receptors previously deblocked by depolarization of postsynaptic membranes; sodium and calcium enter the cell, initiating a cascade of biochemical and structural changes, such as mitochondrial lesion, proteolysis of microfilaments, breakage of membrane phospholipids, formation of free radicals, and cell death [13]. At the core of ischemic injury, glutamate is released at very high concentrations: approximately 80 times baseline levels. The neurotoxicity of glutamate is irrelevant in this central area of severe injury; however, in the peripheral penumbral tissue, although the concentration of glutamate is lower, its neurotoxic effects are of greater importance. Glutamate release stimulates depolarization in the periphery of cerebral ischemia, as it has been described in propagated depression [21]. The higher frequency of progressive infarcts in cortical areas could be explained by the higher density of glutamatergic neurons in the cortex [22, 36]. Early progression is probably exceptional in subcortical infarcts not involving the basal ganglia: in these cases, deterioration could be due to hemodynamic mechanisms.The release of glutamate and the stimulation of its specific receptors initiates a cascade of chemical reactions, mediated by nitric oxide (NO) and free radicals, that increase tissue injury. NO is synthesized from the amino acid L-arginine and molecular oxygen by the enzyme nitric oxygen synthase (NOS). The excitotoxic role of NO has generated considerable debate because NO may exert a dual role, both as a powerful dilator of cerebral vessels and as a mediator of tissue injury [37]. NO generated in neurons by the neuronal isoform of NOS (iNOS) and in the microglia by NOS is cytotoxic [38]. In patients with acute hemispheric infarction, an association was proven between low L-arginine concentrations in CSF, larger infarcts, and severer neurological deficits at 48 h after onset. These findings suggest consumption of L-arginine during cerebral ischemia, most notably in patients with progressing symptoms [39].The role of oxygen free radicals in ischemic brain injury has been established through the protective effects of radical scavengers and antioxidants. Ferrous iron, such as ferritin, released from intracellular stores during ischemia, catalyzes the formation of the radical hydroxyl, which attacks protein and lipid membranes, disrupting cellular integrity. Thus, the sensitivity of neurons to oxidative stress depends on the availability of iron in the ischemic area [40]. Some clinical studies suggest that increased body iron stores favor brain injury and stroke progression [40, 41].The mechanism by which these biochemical changes affect the progression of the infarct is only partially known. The potential of glutamate to induce cell swelling is well known [42, 43]. The presence of early hypodensity on brain CT associated with progressing stroke [4, 8]probably represents intracellular edema. This intracellular edema is not sufficient to produce mass effect, which explains the lack of association between this finding on the CT scan and early neurological deterioration [2, 4, 6, 8]. However, cytotoxic edema is followed by an increase in vascular permeability and the development of vasogenic edema, which explains the delayed neurological deterioration in patients with extensive infarcts [44].Lactic acidosis is another important mechanism of intracellular ischemic edema. When pH decreases, the exchange of excess intracellular H+ with extracellular Na+ is stimulated, leading to the accumulation of water in the cell. High levels of glycemia during the acute phase of cerebral ischemia give rise to an increase in lactic acid levels and have been related to the progression of ischemic stroke [2, 3, 4, 8]. However, while this mechanism is true in diabetic patients, in nondiabetic patients with adequate collateral blood supply, transient hyperglycemia may theoretically play a protective role [45]. It has also been shown in nondiabetic patients that the ischemia-induced rise in glutamate is attenuated by exogenous glucose delivery [46].The mechanisms by which hyperthermia influences neurological damage are only partially elucidated. During transient middle cerebral artery occlusion, glutamate release within the ischemic penumbra is significantly higher in hyperthermic than in normothermic rats [47]. Further, the concentration of glutamate in CSF is significantly higher in hyperthermic than in normothermic patients. Body temperature is related to the progression and size of the infarct, but this effect is dependent upon the neurotoxicity of the glutamate [48]. The mechanism that causes an increased release of neuroexcitatory amino acids in hyperthermia is unknown, although one compelling hypothesis is that it depends on the diffusibility of glutamate from the infarct core (where the concentrations of these amino acids are very high) to the peripheral zone of ischemic penumbra [48]. Another mechanism that has been suggested is that hyperthermia causes a depletion in adenosine triphosphate, which makes glutamate re-uptake difficult and affects its accumulation in the cell [49]. In addition to excitotoxicity, processes mediated by oxygen radicals may also play a major contribution in the pathogenesis of ischemic brain injury by hyperthermia [50].Another controversial issue is whether stroke worsening is related to the development of seizures during the acute phase of CI. In large clinical studies, seizures are more frequent in more seriously ill patients [51, 52]and are associated with higher mortality [53, 54]and morbidity [53, 55], particularly in cortical infarcts as the result of the increased concentration of extracellular glutamate in cortical areas [56].It has been claimed that progressive tightening of an arterial stenosis leading to vessel occlusion could enlarge the size of the infarction. However, there is no angiographic confirmation of this mechanism and large transcranial Doppler studies have not been able to confirm this hypothesis [31].Thrombus progression has also been put forward as one of the fundamental mechanisms in progressive infarction despite the lack of angiographic data and the negative results obtained in anticoagulated patients. This mechanism could explain stroke progression in patients with large vessel disease of the upper third of the basilar artery. As well, it was recently found that the occlusion of the carotid siphon was associated with the progression of hemispheric infarctions [4]. In contrast, adequate collateral blood supply and early spontaneous recanalization are likely to be the mechanisms underlying early clinical improvement [57].While the role of the macrovascular thrombus propagation remains in question, experimental models have shown progressive microvascular obstruction leading to a significant reduction of the microcirculatory perfusion within the core of the ischemic region. The development of a more severe perfusion deficit in the penumbra within 4 h from middle cerebral artery occlusion supports that microcirculatory failure also contributes to the recruitment of ischemic penumbra into infarction [58]. In animal models, it has been shown that hyperglycemia hampers arterial reperfusion because it gives rise to endothelial edema [59].Leukocytes appear to have a central role in the inflammatory response that develops during acute brain ischemia. Leukocytes accumulate in focal areas of acute brain ischemia at a sufficiently early stage to participate in the progression of ischemic injury and that measures aimed at blocking leukocyte activation result in the attenuation of ischemic damage [60, 61]. High serum levels of interleukin-6, transforming growth factor-β and proteases have been demonstrated at a very early stage in stroke patients [62, 63].The volume of the penumbra area in the early hours of CI may cover 50% of the initial ischemic lesion [64]. Depending upon blood pressure levels, the size of the occluded vessel, and the adequacy of the collateral circulation, the area of penumbra is vulnerable to changes in perfusion pressure because cerebral blood flow autoregulation is disturbed in this area [65]. Angiographic evidence of arterial obstruction and absence of collateral circulation are factors associated with progressive infarction [4]. The lack of collateral circulation is perhaps the hemodynamic factor that determines the neurological deterioration observed in 20–35% of lacunar infarctions [13, 66]. A strong relationship between blood pressure on admission and the risk of developing early stroke in progression was shown [3, 67]. A recent study suggested that patients with multiple stenosis of the cerebral arteries may improve the neurological function upon raising blood pressure [68]. Despite these results, mean values of systolic and diastolic blood pressure recorded within 6 h from onset were not related to neurological worsening in recent studies [4, 68].From a pathological perspective, the progressive infarct signifies an increase in lesion volume, either through spreading of tissue necrosis [69]or through apoptosis [70]. Although the mechanisms triggering immediate or delayed death are not fully understood, it is possible that similar processes participate although with different degrees of intensity and duration [71]. Prolonged and severe ischemia will produce large quantities of neuroexcitatory amino acids, oxidative radicals and NO leading to necrosis, whereas the less severe and short-lasting ischemia will result in lower levels of cytotoxic elements, and the expression of early genes, apoptosis and/or greater ischemic tolerance.In summary, early neurological deterioration is the result of multifactorial processes which involve in a sequential the ischemic penumbra and its peripheral areas of normal cerebral tissue (fig. 1). The reduction in cerebral blood flow below a particular threshold and for a sufficient amount of time (both variables depend on the arterial territory and the cerebral and systemic hemodynamics of the patient) [72]is the harbinger of CI [35, 73]. Brain edema explains neurological deterioration in a large proportion of patients [25]. Ischemic brain edema is plurietiologic and pluripathogenic: glutamate and other biochemical abnormalities, lack of collateral flow, and other hemodynamic alterations are important factors. Several acute phase reactants, such as hyperthermia or hyperglycemia, are also involved in brain edema formation [33]. Brain edema also leads to progressing failure of the microcirculation and enlargement of the penumbral zone at the expense of the surrounding healthy tissue [58]. This recruitment of more normal cerebral tissue is favored by cytokine-mediated inflammatory processes, the activation of leukocytes and their adhesion to the endothelium [60, 61, 62, 63, 74].Some therapeutic measures have been associated with a decline in the incidence of progressing stroke. In recent years, researchers’ interest has focussed on the first hours after the stroke onset. The duration of tissue viability and, in consequence, the window of opportunity for therapy have boosted the concept of stroke as a neurological emergency [75]. Urgent care given to patients with stroke improves their prognosis [76]and reduces the risk of early neurological damage [5, 8].Therapeutic measures in progressing stroke must be aimed at correcting hemodynamic changes and at blocking biochemical changes and their consequences, both of which are associated with neurological deterioration. Anticoagulants have not been shown to be beneficial in preventing early neurological deterioration. Nevertheless, heparin is the most frequently used drug in treating progressing stroke. To date, there is no evidence to the use of for this even it has been demonstrated that hemorrhagic transformation of the infarct not stroke prognosis that this risk may be with sufficient in the acute phase and that of levels may also hemorrhagic deterioration in patients with large infarcts The of in treating progressing stroke has not been with leukocyte adhesion reduces neurological deficit in experimental models of stroke. However, a recently of an that it is of no compared with therapy has been for treating after The of this therapy in progressive stroke has not been although a lower incidence of deficits have been described in patients with severe carotid stenosis of hyperglycemia in diabetic and cerebral edema are despite the lack of studies the of these therapy is more although it may be in patients with large hemorrhagic infarcts of the which are more frequently with seizures with has not the risk of progressive stroke carotid may be beneficial in some cases, although need to be on an basis on the of the mechanisms involved in progressing stroke it is that could an effective therapeutic It is also likely that the of will be greater the the At the same that at a of levels in the ischemic cascade may be more effective than those with a single mechanism Although the of is probably greater the earlier it is found a of CSF glutamate to 24 h after stroke onset in patients with progressing stroke, while glutamate to normal values in less than 6 h from onset in those with stable stroke Although the increase of amino acids is in animal stroke models, findings suggest that in some patients, the brain is at risk of a of and that a window of opportunity for glutamate in preventing early deterioration in acute ischemic stroke.
No takes yet. Share an insight, caveat, or question.
José Castillo (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: